About AtriCure

AtriCure, Inc. is a medical device company that provides innovative solutions designed to decrease the global Afib epidemic. AtriCure’s Isolator® Synergy™ Ablation System is the first and only surgical device approved for the treatment of persistent and longstanding persistent forms of Afib in patients undergoing certain open concomitant procedures. AtriCure’s AtriClip® Left Atrial Appendage Management (LAAM) exclusion device is the most widely sold device worldwide that is indicated for the occlusion of the left atrial appendage. AtriCure believes electrophysiologists and cardiothoracic surgeons are adopting its technologies for the treatment of Afib and reduction of Afib related complications. Afib affects more than 33 million people worldwide. For more information, visit or follow us on Twitter @AtriCure.


Product Development Co-op

January 2019 - August 2019 Mason, OH
“AtriCure truly cares about you as an individual and what you want to learn and experience. If you do multiple rotations there, they ensure that you move around, giving you a large range of experience.”

Cryo Product Development Co-op

January 2019 - August 2019 Mason, OH
“I loved the atmosphere and culture of the place. Everyone there was very welcoming and wanted to help you learn and grow in your major and to succeed at AtriCure. Everyone loved the work they did and always went above and beyond when clarification or more knowledge was needed.”
See All